DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

Eden vs Fridays: November 2026 prices compared

As of November 20, 2026, from each program’s own page: on compounded tirzepatide, only Eden prints a comparable month-to-month price, $129 a month; Fridays shows only a starting-dose or coupon figure (from $99, "as low as" with a coupon code), so no like-for-like comparison is possible.

Released · Last reviewed · how we verify

On compounded semaglutide, only Eden prints a comparable month-to-month price, $99 a month; Fridays shows only a starting-dose or coupon figure (from $69, with a coupon code), so no like-for-like comparison is possible.

Eden and Fridays, measure by measure

Eden and Fridays side by side, from each program’s own page read November 20, 2026 (all-in: medication plus any required recurring fee, before tax)
MeasureEdenFridays
Tirzepatide, month to month$129 (per month)from $99 (lowest printed: "as low as" with a coupon code; no month-to-month figure)
Tirzepatide, lowest printed$129 (every month)$99 ("as low as" with a coupon code)
Semaglutide, month to month$99 (per month)from $69 (lowest printed: with a coupon code; no month-to-month figure)
Semaglutide, lowest printed$99 (every month)$69 (with a coupon code)
Dose pricingsame price at every dosepriced by dose or not stated
Membership or program feenonenone
Computed score34.3 of 40 (position 3 of 27)12 of 40 (position 16 of 27)
FDA warning letters728279 (2026-06-08)none listed
November 20 readfirst-party readfirst-party read, promotional

Strengths and limitations: which fits whom

Eden prints one price at every dose with no membership, so a dose increase does not change the bill. Fridays prints a month-to-month price; confirm whether it changes with the dose before you rely on it for a year. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy; a licensed clinician decides whether either is appropriate for you.

What changed since August

The first version of this comparison used captures from August 5–10, 2026. The November 20 re-read replaces them; the August figures are kept below as history, dated.

What changed since the August 2026 capture (maintenance-dose all-in figure then; month-to-month all-in figure read November 20, 2026)
ProgramMedicationAugust 5–10, 2026November 20, 2026
Edentirzepatide$408$129
Edensemaglutide$198$99
Fridaystirzepatide—from $99
Fridayssemaglutide—from $69

Regulatory record

FDA’s warning-letter index lists warning letter 728279 (dated June 8, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to Eden; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.

Check Eden’s current prices ↗
Check Fridays’s current prices ↗

Frequently asked

Which is cheaper, Eden or Fridays?

On compounded tirzepatide, only Eden prints a comparable month-to-month price, $129 a month; Fridays shows only a starting-dose or coupon figure (from $99, "as low as" with a coupon code), so no like-for-like comparison is possible. On compounded semaglutide, only Eden prints a comparable month-to-month price, $99 a month; Fridays shows only a starting-dose or coupon figure (from $69, with a coupon code), so no like-for-like comparison is possible.

Do Eden and Fridays charge a membership fee?

Eden: no membership fee; Fridays: no membership fee. This site folds any required recurring fee into the all-in figures above, so the comparison already counts it.

Are Eden and Fridays medications FDA-approved?

Compounded tirzepatide and semaglutide from any telehealth program are not FDA-approved and are not the same products as Zepbound, Mounjaro, Wegovy or Ozempic. Brand medications sold through a manufacturer or a brand route are FDA-approved. Ask each program which pharmacy fills the prescription.

Eden recordEden alternativesFridays recordFridays alternativesAll head-to-headsRankingsPrice database

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.